Replies to post #1548 on Idenix Pharmaceuticals (IDIX)

[DewDiligence]

>This, IMO, goes a long way towards explaining the rapid uptake of entecavir.<

Huh? Entecavir’s sales uptake was far from rapid. Worldwide sales in the first four quarters on the market were $5M, $2M, $5M, and $11M, respectively (#msg-21567340). The reason for the slowness of the uptake has been discussed on this board on numerous occasions.

[gofishmarko]

I just found the site for the conference where Locarnini presented and they have the video , which is a lot better than trying to figure out the transcript.

Also a video and the slides of this :

HBV: Evolving Treatment Paradigms in HIV-HBV Co-Infected Patients
Vincent Soriano, M.D., Ph.D.


and video only of :

Small Molecular Inhibitors of HCV Infection: Agents in the Pipeline
Marion Peters, M.D.

http://www.kaisernetwork.org/health_cast/hcast_index.cfm?display=detail&hc=2234